- Filed
- Nov 5, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2025 · Oct 30, 2025 | 394.88M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2025 | 429.25M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2025 | 390.62M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2024 | 385.73M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2024 | 383.01M sh |
| Capex | Q3 2025 · Sep 30, 2025 | $59.42M |
| Capex restated | Q3 2025 · Sep 30, 2024 | $64.84M |
| Long Term Debt | Q3 2025 · Sep 30, 2025 | $4.06B |
| Long Term Debt | Q3 2025 · Dec 31, 2024 | $4.83B |
| Cash And Equivalents | Q3 2025 · Sep 30, 2025 | $661.72M |
| Cash And Equivalents | Q3 2025 · Dec 31, 2024 | $724.48M |
| Stockholders Equity | Q3 2025 · Sep 30, 2025 | −$950.81M |
| Stockholders Equity | Q3 2025 · Jun 30, 2025 | −$1.8B |
| Stockholders Equity | Q3 2025 · Mar 31, 2025 | −$1.56B |
| Stockholders Equity | Q3 2025 · Dec 31, 2024 | −$1.6B |
| Stockholders Equity | Q3 2025 · Sep 30, 2024 | −$1.54B |
| Stockholders Equity | Q3 2025 · Jun 30, 2024 | −$1.49B |
| Stockholders Equity | Q3 2025 · Mar 31, 2024 | −$1.43B |
| Stockholders Equity | Q3 2025 · Dec 31, 2023 | −$1.38B |
| Current Liabilities | Q3 2025 · Sep 30, 2025 | $1.02B |
| Current Liabilities | Q3 2025 · Dec 31, 2024 | $1.14B |
| Current Assets | Q3 2025 · Sep 30, 2025 | $1.16B |
| Current Assets | Q3 2025 · Dec 31, 2024 | $1.16B |
| Total Assets | Q3 2025 · Sep 30, 2025 | $4.37B |
| Total Assets | Q3 2025 · Dec 31, 2024 | $4.63B |
| Eps Diluted | Q3 2025 · Sep 30, 2025 | $1.98 |
| Eps Diluted | Q3 2025 · Sep 30, 2025 | $1.61 |
| Eps Diluted | Q3 2025 · Sep 30, 2024 | −$0.16 |
| Eps Diluted | Q3 2025 · Sep 30, 2024 | −$0.53 |
| Eps Basic | Q3 2025 · Sep 30, 2025 | $2.15 |
| Eps Basic | Q3 2025 · Sep 30, 2025 | $1.61 |
| Eps Basic | Q3 2025 · Sep 30, 2024 | −$0.16 |
| Eps Basic | Q3 2025 · Sep 30, 2024 | −$0.53 |
| Sga Expense | Q3 2025 · Sep 30, 2025 | $140.48M |
| Sga Expense | Q3 2025 · Sep 30, 2025 | $399.6M |
| Sga Expense restated | Q3 2025 · Sep 30, 2024 | $149.39M |
| Sga Expense restated | Q3 2025 · Sep 30, 2024 | $433.47M |
| Operating Income | Q3 2025 · Sep 30, 2025 | $93.63M |
| Operating Income | Q3 2025 · Sep 30, 2025 | $274.15M |
| Operating Income restated | Q3 2025 · Sep 30, 2024 | $57.84M |
| Operating Income restated | Q3 2025 · Sep 30, 2024 | $195.76M |
| Cost Of Revenue | Q3 2025 · Sep 30, 2025 | $313.07M |
| Cost Of Revenue | Q3 2025 · Sep 30, 2025 | $914.9M |
| Cost Of Revenue restated | Q3 2025 · Sep 30, 2024 | $294.66M |
| Cost Of Revenue restated | Q3 2025 · Sep 30, 2024 | $880.71M |
| Revenue | Q3 2025 · Sep 30, 2025 | $715.18M |
| Revenue | Q3 2025 · Sep 30, 2025 | $2.1B |
| Revenue restated | Q3 2025 · Sep 30, 2024 | $691.3M |
| Revenue restated | Q3 2025 · Sep 30, 2024 | $2.1B |